Sign in
4

Changes in Ownership

Twist Bioscience Corp Filed Acc 0001214659-26-010968

Chief Executive Officer sold 41,570 shares at an average $151.98 ($6,317,760)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Leproust Emily M. · Chief Executive Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-25 Sale : show line 1 in the form 10b5-1 −12,648 $150.56 $1,904,333 799,651 D
2026-08-25 Sale : show line 2 in the form 10b5-1 −12,236 $151.36 $1,851,980 787,415 D
2026-08-25 Sale : show line 3 in the form 10b5-1 −6,412 $152.75 $979,433 781,003 D
2026-08-25 Sale : show line 4 in the form 10b5-1 −9,181 $153.93 $1,413,204 771,822 D
2026-08-25 Sale : show line 5 in the form 10b5-1 −1,093 $154.45 $168,809 770,729 D
Open-market sales · 41,570 sh · avg $151.98 · $6,317,760
Loading xslF345X06/marketforms-73903.xml…